GCG and Parkinson disease: A brain-penetrant GLP1 analog is shown to protect against dopaminergic neuronal death in an α-syn preformed fibril mouse model of PD [127]; in this study, the GLP1 analog prevents microglia from converting astrocytes to a neurotoxic phenotype, hence preventing the death of dopaminergic neurons.